Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.40
Bid: 0.00
Ask: 152.80
Change: 0.00 (0.00%)
Spread: 14.80 (10.725%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 137.40
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

26 Jan 2017 07:00

RNS Number : 1466V
Kier Group PLC
26 January 2017
 

26 January 2017

 

KIER GROUP PLC

TRADING UPDATE

Kier Group plc, a leading property, residential, construction and services group, provides an update for the half year ended 31 December 2016 ("the period") prior to announcing its half year results on 23 March 2017.

Current trading

The Group's underlying trading performance for the period was in line with management's expectations, with the results for the full year expected to be second-half weighted in line with the prior year.

 

Financial position

The Group's net debt position for the six months ended 31 December 2016 was £179m (31 December 2015: £174m) which includes receipt of the proceeds from the disposal of Mouchel Consulting and an investment of £100m since 1 July 2016 in the Property and Residential divisions to take advantage of attractive investment opportunities and drive future growth for the Group. The average month-end net debt position for the period was in line with prior year at £300m (31 December 2015: £280m). We expect to maintain a net debt to EBITDA ratio of less than 1x at 30 June 2017.

 

Operational update

Each of the Group's divisions continue to perform well.

 

The Property division has maintained its good performance benefiting from the continued investment in new schemes. It has a pipeline of more than £1bn and continues to deliver ROCE in excess of 15%. The period was underpinned by strong occupier activity and healthy investment sentiment across all sectors. We completed a number of disposals throughout the UK and a schedule of pre-lets were secured with additional lettings at an advanced stage and on track for exchanging before our financial year end.

 

The Residential division continues to benefit from the demand in the UK for all forms of housing. We continue to recycle capital from our private land bank into our mixed-tenure business and improve the division's ROCE through the use of cash efficient joint ventures. In early January, the division secured a £42m four-year allocation from the Homes and Communities Agency which will underpin the delivery of completions from 2019 onwards. Our private sales are performing well with strong sales, visitor and reservation rates. The division is on track to deliver more than 2,200 completions by 30 June 2017.

 

The Construction and Services divisions continue to perform well, and we are continuing with the closure of our Caribbean operations. Total contract awards since mid-November 2016 have totalled more than £1bn, and the Construction and Services order books represent 100% of forecast revenue for the 2017 financial year.

 

Key contract awards since mid-November include:

· three new highways maintenance contracts worth more than £300m covering Highway England's Areas 6, 8 and 13;

· the award of a new 50/50 joint venture infrastructure contract with Severn Trent on the Birmingham Resilience Project worth £100m;

· a £80m contract for the construction of the Cardiff University Innovation Campus;

· a contract awarded to deliver phase 2 of the £85m extension to Eastbourne Arndale Shopping Centre for Eastbourne Borough Council and Legal & General; and

· a £75m contract in Dubai to deliver a second staff accommodation project on behalf of Nshmi, a local developer and existing client. This project will be funded with the support of UK Export Finance. 

 

Outlook

The Group continues to experience good underlying organic growth. The strength of the Property pipeline, the good forward sold position in the Residential division and the combined Construction and Services order book, which has been maintained at approximately £9bn excluding potential further renewals and extensions valued in excess of £2.5bn, positions the Group well for the future.

- ENDS -

 

For further information, please contact:

Kier press office

+44 (0) 1767 355 903/ +44 (0) 7791 719452

Louise Turner-Smith, Head of investor relations

+44 (0) 7976 790012

 

Cautionary statement

 

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2016 for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUUWGUPMGBA
Date   Source Headline
4th Nov 20223:04 pmRNSHolding(s) in Company
3rd Nov 20223:27 pmRNSDirector/PDMR Shareholding
1st Nov 20224:34 pmRNSDirector/PDMR Shareholding
1st Nov 202210:07 amRNSTotal Voting Rights
25th Oct 20223:35 pmRNSHolding(s) in Company
24th Oct 20222:28 pmRNSDirector/PDMR Shareholding
19th Oct 20224:17 pmRNSDirector/PDMR Shareholding
12th Oct 20223:59 pmRNSHolding(s) in Company
7th Oct 202211:51 amRNSAnnual Financial Report
3rd Oct 202210:23 amRNSTotal Voting Rights
21st Sep 20223:42 pmRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSResults for the year ended 30 June 2022
2nd Sep 202210:08 amRNSHolding(s) in Company
1st Sep 202210:21 amRNSTotal Voting Rights
22nd Aug 202210:11 amRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSTotal Voting Rights
29th Jul 20224:05 pmRNSHolding(s) in Company
20th Jul 202212:00 pmRNSDirector/PDMR Shareholding
19th Jul 20227:00 amRNSTrading Update
6th Jul 20227:00 amRNSBoard Appointment
1st Jul 202210:16 amRNSTotal Voting Rights
1st Jul 202210:14 amRNSBlock listing Interim Review
28th Jun 20229:41 amRNSHolding(s) in Company
22nd Jun 20224:29 pmRNSHolding(s) in Company
21st Jun 202211:44 amRNSDirector/PDMR Shareholding
1st Jun 202210:36 amRNSTotal Voting Rights
24th May 20227:00 amRNSTrading Update and Capital Markets Event
20th May 20222:36 pmRNSDirector/PDMR Shareholding
3rd May 202210:30 amRNSTotal Voting Rights
29th Apr 20221:00 pmRNSDirector Declaration
19th Apr 20224:32 pmRNSDirector/PDMR Shareholding
1st Apr 202212:28 pmRNSTotal Voting Rights
21st Mar 20222:05 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSResults for the six months ended 31 December 2021
1st Mar 202212:07 pmRNSTotal Voting Rights
21st Feb 20223:08 pmRNSDirector/PDMR Shareholding
2nd Feb 20223:05 pmRNSHolding(s) in Company
1st Feb 202212:07 pmRNSTotal Voting Rights
20th Jan 202212:18 pmRNSDirector/PDMR Shareholding
20th Jan 20227:00 amRNSTrading Update
4th Jan 202212:05 pmRNSTotal Voting Rights
4th Jan 202212:00 pmRNSBlock listing Interim Review
20th Dec 20214:10 pmRNSDirector/PDMR Shareholding
1st Dec 20212:37 pmRNSTotal Voting Rights
22nd Nov 20213:14 pmRNSDirector/PDMR Shareholding
19th Nov 20212:32 pmRNSResult of AGM
15th Nov 20211:13 pmRNSHolding(s) in Company
1st Nov 20213:17 pmRNSDirector/PDMR Shareholding
1st Nov 20219:38 amRNSTotal Voting Rights
29th Oct 202112:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.